At MLS Bio we are addressing the world’s most critical health challenges through patented, novel small-molecule therapies with our breakthrough compounds targeting a new cellular mode of action, offering novel approaches to treatment in the most impactful global markets.
Our Global team of experienced medical researchers, commercialization and technical experts are committed to developing treatments that are more effective, accessible, and better tolerated, delivering novel solutions and improving the lives of patients facing cancer and other life-threatening diseases worldwide.
Our Strategic Focus is Oncology, where we are advancing a robust pipeline targeting unmet needs in solid tumor cancers.
We aim to develop solutions in other high-impact global markets, bringing transformative therapies to market, delivering better outcomes for patients facing cancer and other life-threatening diseases, improving lives worldwide.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Studley Rd, Heidelberg,victoria 3084,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mlsbio.com
- Keywords
- Melbourne.
- HQ
- Heidelberg, Victoria
Mls Bio (Molecular Life Science Biotech) Questions
Mls Bio (Molecular Life Science Biotech)'s website is http://www.mlsbio.com
Mls Bio (Molecular Life Science Biotech)'s LinkedIn profile is https://au.linkedin.com/company/mls-bio
Mls Bio (Molecular Life Science Biotech) has
5 employees.
View email and phone details for 5
employees at Mls Bio (Molecular Life Science Biotech).
Mls Bio (Molecular Life Science Biotech)'s industry is
Biotechnology Research
Mls Bio (Molecular Life Science Biotech)'s top competitors are
Chimeric Therapeutics,
Immuron,
Polyactiva,
Munchkins Talent Agency,
Meizon Innovation,
Atticus Medical,
Psc Biotech - Australia,
Inosi Therapeutics Pty Ltd,
Amplia Therapeutics Limited,
Invion Limited.
Mls Bio (Molecular Life Science Biotech)'s categories are Biotechnology Research
Mls Bio (Molecular Life Science Biotech)'s founding year is 2017
